Expression of autophagy-related factor p62 for lung cancer diagnosis and prognosis: a systematic review and meta-analysis
From MaRDI portal
Publication:2045490
DOI10.3934/MBE.2019340zbMATH Open1470.92156OpenAlexW2965110914WikidataQ91167866 ScholiaQ91167866MaRDI QIDQ2045490FDOQ2045490
Bijiong Wang, Hui Xu, Yaodong Tang, Di Gui, Biyun Yu
Publication date: 13 August 2021
Published in: Mathematical Biosciences and Engineering (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.3934/mbe.2019340
Recommendations
- Genome-wide haplotype association study identifies risk genes for non-small cell lung cancer
- A model-strengthened imaging biomarker for survival prediction in EGFR-mutated non-small-cell lung carcinoma patients treated with tyrosine kinase inhibitors
- Identification of key microRNAs involved in tumorigenesis and prognostic microRNAs in breast cancer
- MIB-1, AgNOR AND DNA DISTRIBUTION PARAMETERS AND THEIR PROGNOSTIC VALUE IN NEUROENDOCRINE TUMOURS OF THE LUNG
- Prognostic factor identification by analysis of the gene expression and DNA methylation data in glioma
This page was built for publication: Expression of autophagy-related factor p62 for lung cancer diagnosis and prognosis: a systematic review and meta-analysis
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2045490)
